News
🇪🇺 EuropeLatest pharmaceutical news, drug approvals, and EMA regulatory updates
Latest News
RNA Therapy Clinical Trials Market Reaches $3.4 Billion as Personalized Medicine Drives Growth Through 2035
RNA therapy clinical trials market hits $3.4B driven by delivery advances, rare disease funding, and personalized medicine growth through 2035.
Oncotelic Therapeutics Updates Partnership Strategy for Cancer Drug Development Pipeline
Oncotelic Therapeutics provides corporate update on strategic partnerships to advance clinical-stage cancer treatments and expand market reach.
CLINUVEL Receives EMA Approval for SCENESSE Phase III Vitiligo Trial Starting 2026
CLINUVEL gets final EMA scientific advice for pivotal Phase III vitiligo study comparing SCENESSE with NB-UVB therapy, set to begin second half 2026.
RenovoRx TAMP Therapy Platform Data Accepted for 2026 ASCO Presentation - Phase III TIGeR-PaC Trial Results
RenovoRx announces ASCO acceptance of pharmacokinetic data from Phase III TIGeR-PaC trial testing TAMP therapy platform for pancreatic cancer treatment.
Genomics Services Market to Reach $24 Billion by 2033 as Precision Medicine Adoption Accelerates
The global genomics services market is projected to grow at 11.2% CAGR through 2033, driven by precision medicine advances and digital health initiatives.
Accenture Invests in Iridius to Accelerate AI Compliance Solutions for Life Sciences Companies
Accenture Ventures invests in Iridius to help pharmaceutical companies adopt compliant AI solutions while maintaining regulatory standards and auditability.
Pharmaceutical Company Reports Continued Growth Momentum in Q1 2026 Sales Results
Major pharmaceutical company announces sustained growth in first quarter 2026 sales, maintaining positive momentum from previous periods with investor call scheduled.
Cumberland Pharmaceuticals Announces Strategic Integration with Apotex in Major Commercial Partnership Deal
Cumberland Pharmaceuticals (CPIX) enters strategic agreement with Apotex to integrate commercial operations, marking significant shift in specialty pharma landscape.
Reuters Pharma EU: Key Takeaways Day 1
Reuters Events: Pharma EU conference convenes pharmaceutical industry leaders to discuss regulatory developments, market trends, and innovation strategies across European markets. Day 1 establishes key themes and networking opportunities for industry collaboration.
Tilray Brands Positioned for Major U.S. Medical Cannabis Expansion Following Historic Rescheduling
Tilray Brands leverages international medical cannabis expertise across 20+ countries to capitalize on U.S. market expansion opportunities amid cannabis rescheduling.
Center for Cancer and Blood Disorders Launches CAR T-Cell Therapy Program in Maryland, Expanding Community Access
CCBD becomes first Maryland community oncology practice to offer FDA-approved CAR T-cell therapy, significantly expanding patient access in the region.
SamaCare Launches Industry-First Prior Authorization Performance Benchmarks for Medical Benefit Drugs
SamaCare introduces first-of-its-kind benchmarks tracking prior authorization approval rates and time to therapy across specialty practices nationwide.
Repertoire Immune Medicines Doses First Patient in RPTR-1-201 Phase 1/2 Trial for Advanced Solid Tumors
Repertoire Immune Medicines begins Phase 1/2 trial of RPTR-1-201, a novel TCR bispecific therapy targeting advanced solid tumors across US and European sites.
Alpha Tau Treats First Patient with Alpha DaRT in European Pancreatic Cancer Trial ACAPELLA
Alpha Tau initiates Alpha DaRT treatment in ACAPELLA trial for locally advanced pancreatic cancer, addressing unmet need for 42,000 European patients annually.
Alpha Tau Treats First European Pancreatic Cancer Patient with Alpha DaRT in ACAPELLA Clinical Trial
Alpha Tau successfully treats first European patient with Alpha DaRT radiotherapy in French ACAPELLA trial for locally advanced pancreatic cancer.
Blinatumomab Long-Term Safety Study in Pediatric Leukemia Patients Reaches Final Stage
European study evaluating long-term safety of blinatumomab versus chemotherapy in pediatric acute lymphoblastic leukemia patients nears completion.
Healthcare Third-Party Logistics Market to Double by 2034, Reaching $502.6 Billion Driven by Pharmaceutical Growth
Healthcare 3PL market projected to grow from $246.1B to $502.6B by 2034 at 7.8% CAGR, driven by pharmaceutical expansion and cold chain logistics demand.
Pharmaceutical Intermediates Market to Reach $57 Billion by 2035 as Generic Drug Manufacturing Drives 4.5% Annual Growth
Global pharmaceutical intermediates market projected to grow from $36.62B to $57.03B by 2035, driven by generic drug demand and advanced manufacturing.
Reuters Pharma Day 1: Key Takeaways for European Markets
Reuters Events: Pharma Day 1 highlights fragmented European market access strategies, accelerating AI-driven drug development, and evolving regulatory frameworks reshaping the pharmaceutical landscape across the EU.
Reuters Pharma EU: Day 1 Key Takeaways for Pharma Leaders
Reuters Pharma EU Day 1 coverage requires verified event data and official conference materials to deliver accurate insights. NovaPharmaNews is prepared to provide comprehensive analysis once speaker information, session details, and announced developments are available.